Top compounds associated with response to DNLZ


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.027 0.4
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.4
mRNA Bortezomib gCSI pan-cancer AAC 0.048 0.4
mRNA BYL-719 CTRPv2 pan-cancer AAC -0.032 0.4
mRNA YL54 CTRPv2 pan-cancer AAC 0.029 0.4
mRNA valdecoxib CTRPv2 pan-cancer AAC -0.026 0.4
mRNA sotrastaurin CTRPv2 pan-cancer AAC 0.029 0.5
mRNA GMX-1778 CTRPv2 pan-cancer AAC -0.026 0.5
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
mRNA tivantinib CTRPv2 pan-cancer AAC -0.033 0.5
Download CSV